HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Roberto Patuzzo Selected Research
Roberto Patuzzo Research Topics
Disease
23
Melanoma (Melanoma, Malignant)
06/2022 - 02/2003
18
Neoplasms (Cancer)
01/2022 - 04/2005
4
Neoplasm Metastasis (Metastasis)
01/2021 - 04/2009
1
Extranodal Extension
01/2021
1
Tics (Tic)
10/2016
1
Disease Progression
08/2015
1
Head and Neck Neoplasms (Head and Neck Cancer)
02/2015
1
Cicatrix (Scar)
02/2015
1
Hyperthermia
02/2013
Drug/Important Bio-Agent (IBA)
7
Antigens
IBA
05/2013 - 05/2006
6
Peptides (Polypeptides)
IBA
05/2013 - 05/2006
4
Interleukin-2 (IL2)
IBA
08/2015 - 04/2005
3
Monoclonal Antibodies
IBA
08/2015 - 06/2009
3
Cytokines
IBA
08/2015 - 02/2013
3
Vaccines
IBA
08/2009 - 08/2006
2
Proteins (Proteins, Gene)
FDA Link
01/2015 - 02/2013
2
Melphalan (Alkeran)
FDA Link
Generic
02/2013 - 02/2003
2
Cancer Vaccines
IBA
12/2012 - 08/2009
2
MART-1 Antigen
IBA
07/2010 - 05/2006
2
Heat-Shock Proteins (Heat-Shock Protein)
IBA
08/2006 - 08/2006
1
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
12/2021
1
Capsules (Microcapsules)
IBA
01/2021
1
A-factor (Streptomyces)
IBA
01/2021
1
Immune Checkpoint Inhibitors
IBA
12/2018
1
MicroRNAs (MicroRNA)
IBA
12/2018
1
Indicators and Reagents (Reagents)
IBA
12/2018
1
Interleukin-6 (Interleukin 6)
IBA
10/2016
1
Interleukin-8 (Interleukin 8)
IBA
10/2016
1
Interleukin-10 (Interleukin 10)
IBA
10/2016
1
Chemokines
IBA
10/2016
1
Bleomycin (Blenoxane)
FDA Link
Generic
02/2015
1
Antibodies
IBA
01/2015
1
Thymidine Kinase
IBA
06/2013
1
Neoplasm Antigens (Tumor Antigens)
IBA
06/2013
1
HLA-A*02:01 antigen
IBA
05/2013
1
Cyclophosphamide (Cytoxan)
FDA Link
Generic
05/2013
1
Fibronectins (Fibronectin)
IBA
02/2013
1
Polytetrafluoroethylene (Teflon)
FDA Link
01/2013
1
HLA Antigens (Human Leukocyte Antigens)
IBA
12/2012
1
Bovine Serum Albumin
IBA
07/2010
1
Transcription Factors (Transcription Factor)
IBA
07/2010
1
Epitopes
IBA
08/2009
1
Transforming Growth Factor beta1 (TGF beta 1)
IBA
06/2009
1
Interleukin-15 (Interleukin 15)
IBA
06/2009
1
Cell-Free Nucleic Acids
IBA
06/2007
1
Enzymes
IBA
08/2006
1
vitespin
IBA
08/2006
1
Interferon-alpha (Interferon Alfa)
IBA
08/2006
1
Melanoma-Specific Antigens
IBA
08/2006
1
Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
IBA
08/2006
1
DNA (Deoxyribonucleic Acid)
IBA
08/2006
1
Chemokine CCL21
IBA
04/2005
1
Member 14 Tumor Necrosis Factor Receptors
IBA
04/2005
1
Lymphotoxin beta Receptor
IBA
04/2005
1
Ligands
IBA
04/2005
1
Mitomycin (Mitomycin-C)
FDA Link
Generic
02/2003
Therapy/Procedure
7
Therapeutics
12/2021 - 12/2012
5
Immunotherapy
01/2022 - 08/2006
3
Lymph Node Excision (Lymph Node Dissection)
06/2022 - 04/2009
1
Duration of Therapy
12/2021
1
Intralesional Injections
08/2015
1
Radiotherapy
02/2015
1
Intradermal Injections
07/2010
1
Drug Therapy (Chemotherapy)
08/2006